Contribution of Innate Immune Responses towards Resistance to African Trypanosome Infections

During the course of African trypanosomiasis, an intact monocytic cell system appears to be crucial for the initiation and maintenance of antitrypanosome responses and could be critical for the survival of trypanosome‐infected host. Monocytic cells in turn require support from other components of the innate immunity as well as adaptive immunity for effective and sustained control of trypanosome infections. In this review, the contribution of specific components of the innate immune system towards resistance to African trypanosomes is discussed in the context of host survival and the ideas presented are expected to stimulate more debate and research on host innate mechanisms of defence against African trypanosomiasis.

[1]  D. Horn.  Antigenic variation in African trypanosomes , 2014, Molecular and biochemical parasitology.

[2]  B. Namangala.  How the African trypanosomes evade host immune killing , 2011, Parasite immunology.

[3]  R. Wheeler.  The trypanolytic factor-mechanism, impacts and applications. , 2010, Trends in parasitology.

[4]  F. Tacke,et al.  Tip-DC Development during Parasitic Infection Is Regulated by IL-10 and Requires CCL2/CCR2, IFN-γ and MyD88 Signaling , 2010, PLoS pathogens.

[5]  B. Vanhollebeke,et al.  Cellular and Molecular Remodeling of the Endocytic Pathway during Differentiation of Trypanosoma brucei Bloodstream Forms , 2010, Eukaryotic Cell.

[6]  P. De Baetselier,et al.  Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis. , 2010, Microbes and infection.

[7]  B. Vanhollebeke,et al.  The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill , 2010, Molecular microbiology.

[8]  T. Baral.  Immunobiology of African Trypanosomes: Need of Alternative Interventions , 2010, Journal of biomedicine & biotechnology.

[9]  P. De Baetselier,et al.  Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis. , 2009, The Journal of infectious diseases.

[10]  L. Lins,et al.  C-Terminal Mutants of Apolipoprotein L-I Efficiently Kill Both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense , 2009, PLoS pathogens.

[11]  J. Raper,et al.  Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes , 2009, Proceedings of the National Academy of Sciences.

[12]  Bailey E. Freeman,et al.  Processing and Presentation of Variant Surface Glycoprotein Molecules to T Cells in African Trypanosomiasis1 , 2009, The Journal of Immunology.

[13]  P. Boysen,et al.  Bovine natural killer cells. , 2009, Veterinary immunology and immunopathology.

[14]  J. Rodgers.  Human African trypanosomiasis, chemotherapy and CNS disease , 2009, Journal of Neuroimmunology.

[15]  S. Akira,et al.  iNOS-Producing Inflammatory Dendritic Cells Constitute the Major Infected Cell Type during the Chronic Leishmania major Infection Phase of C57BL/6 Resistant Mice , 2009, PLoS pathogens.

[16]  Scott A. Brown,et al.  TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection , 2009, Proceedings of the National Academy of Sciences.

[17]  P. De Baetselier,et al.  Both type-I and type-II responses contribute to murine trypanotolerance. , 2009, The Journal of veterinary medical science.

[18]  P. De Baetselier,et al.  IL-10 Dampens TNF/Inducible Nitric Oxide Synthase-Producing Dendritic Cell-Mediated Pathogenicity during Parasitic Infection1 , 2009, The Journal of Immunology.

[19]  E. Hill,et al.  Transcriptional profiling of cattle infected with Trypanosoma congolense highlights gene expression signatures underlying trypanotolerance and trypanosusceptibility , 2009, BMC Genomics.

[20]  Karen P. Demick,et al.  Type I IFNs Play a Role in Early Resistance, but Subsequent Susceptibility, to the African Trypanosomes1 , 2008, The Journal of Immunology.

[21]  S. Magez,et al.  Contributions of experimental mouse models to the understanding of African trypanosomiasis. , 2008, Trends in parasitology.

[22]  P. De Baetselier,et al.  Experimental expansion of the regulatory T cell population increases resistance to African trypanosomiasis. , 2008, The Journal of infectious diseases.

[23]  J. Raper,et al.  Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model , 2008, The Journal of experimental medicine.

[24]  S. Moestrup,et al.  A Haptoglobin-Hemoglobin Receptor Conveys Innate Immunity to Trypanosoma brucei in Humans , 2008, Science.

[25]  P. De Baetselier,et al.  Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. , 2007, The Journal of infectious diseases.

[26]  P. De Baetselier,et al.  A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology1 , 2007, The Journal of Immunology.

[27]  P. De Baetselier,et al.  African Trypanosomiasis: Naturally Occurring Regulatory T Cells Favor Trypanotolerance by Limiting Pathology Associated with Sustained Type 1 Inflammation1 , 2007, The Journal of Immunology.

[28]  P. De Baetselier,et al.  African trypanosomosis: from immune escape and immunopathology to immune intervention. , 2007, Veterinary parasitology.

[29]  J. M. Mansfield,et al.  The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces IκBα Degradation Independently of TRAF6-Mediated TLR Signaling1 , 2007, The Journal of Immunology.

[30]  P. De Baetselier,et al.  Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response. , 2007, The Journal of infectious diseases.

[31]  Yoshihisa Watanabe,et al.  Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum , 2007, Proceedings of the National Academy of Sciences.

[32]  T. Harris,et al.  CpG Oligodeoxynucleotide Treatment Enhances Innate Resistance and Acquired Immunity to African Trypanosomes , 2007, Infection and Immunity.

[33]  G. Wei,et al.  Trypanosoma congolense infections: MHC class II‐restricted immune responses mediate either protection or disease, depending on IL‐10 function , 2007, Parasite immunology.

[34]  C. Sugimoto,et al.  Effects of Exogenous Transforming Growth Factor β on Trypanosoma congolense Infection in Mice , 2007, Infection and Immunity.

[35]  J. M. Mansfield,et al.  The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. , 2007, Journal of immunology.

[36]  B. Vanhollebeke,et al.  Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. , 2006, The New England journal of medicine.

[37]  P. De Baetselier,et al.  Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections. , 2006, The Journal of infectious diseases.

[38]  D. Nolan,et al.  The trypanolytic factor of human serum , 2006, Nature Reviews Microbiology.

[39]  J. Naessens.  International Journal for Parasitology 36 (2006) 521–528 Invited review Bovine trypanotolerance: A natural ability to prevent severe anaemia , 2006 .

[40]  O. Ogunremi,et al.  CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide. , 2006, Microbes and infection.

[41]  L. Abel,et al.  Interest of tumor necrosis factor-alpha -308 G/A and interleukin-10 -592 C/A polymorphisms in human African trypanosomiasis. , 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[42]  C. Burri,et al.  Clinical aspects of 2541 patients with second stage human African trypanosomiasis. , 2006, Acta tropica.

[43]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[44]  J. M. Mansfield,et al.  Regulation of innate and acquired immunity in African trypanosomiasis , 2005, Parasite immunology.

[45]  J. Jannin,et al.  Human trypanosomiasis caused by Trypanosoma evansi in India: the first case report. , 2005, The American journal of tropical medicine and hygiene.

[46]  P. De Baetselier,et al.  The Induction of a Type 1 Immune Response following a Trypanosoma brucei Infection Is MyD88 Dependent1 , 2005, The Journal of Immunology.

[47]  R. Brasseur,et al.  Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes , 2005, Science.

[48]  E. Riley,et al.  Natural killer cells and innate immunity to protozoan pathogens. , 2004, International journal for parasitology.

[49]  M. Loomis,et al.  Characterization of primate trypanosome lytic factors. , 2004, Molecular and biochemical parasitology.

[50]  G. Wei,et al.  Trypanosoma congolense infections: antibody‐mediated phagocytosis by Kupffer cells , 2004, Journal of leukocyte biology.

[51]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[52]  B. Veyret,et al.  Mouse Strain Susceptibility to Trypanosome Infection: An Arginase-Dependent Effect1 , 2004, The Journal of Immunology.

[53]  L. Vanhamme,et al.  Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera. , 2004, Molecular and biochemical parasitology.

[54]  D. Williams,et al.  Mechanisms for the elimination of potentially lytic complement-fixing variable surface glycoprotein antibody-complexes inTrypanosoma brucei , 2004, Parasitology Research.

[55]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[56]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[57]  R. Brasseur,et al.  Apolipoprotein L-I is the trypanosome lytic factor of human serum , 2003, Nature.

[58]  M. Shi,et al.  Experimental African trypanosomiasis: IFN‐γ mediates early mortality , 2003 .

[59]  安達 圭志.  Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism , 2003 .

[60]  A. M. Dávila,et al.  Applications of PCR-based tools for detection and identification of animal trypanosomes: a review and perspectives. , 2002, Veterinary parasitology.

[61]  F. Brombacher,et al.  Infection Stage-Dependent Modulation of Macrophage Activation in Trypanosoma congolense-Resistant and -Susceptible Mice , 2002, Infection and Immunity.

[62]  S. Black,et al.  Serum xanthine oxidase: origin, regulation, and contribution to control of trypanosome parasitemia. , 2002, Antioxidants & redox signaling.

[63]  S. Akira,et al.  Plasmodium berghei Infection in Mice Induces Liver Injury by an IL-12- and Toll-Like Receptor/Myeloid Differentiation Factor 88-Dependent Mechanism1 , 2001, The Journal of Immunology.

[64]  P. De Baetselier,et al.  Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. , 2001, The Journal of infectious diseases.

[65]  P. De Baetselier,et al.  Alternative versus classical macrophage activation during experimental African trypanosomosis. , 2001, Journal of leukocyte biology.

[66]  A. Buguet,et al.  Human Macrophage Tumor Necrosis Factor (TNF)–α Production Induced by Trypanosoma brucei gambiense and the Role of TNF-α in Parasite Control , 2001 .

[67]  P. De Baetselier,et al.  Alternative versus classical macrophage activation during experimental African trypanosomosis , 2001, International journal for parasitology.

[68]  P. De Baetselier,et al.  Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control. , 2001, The Journal of infectious diseases.

[69]  B. Veyret,et al.  l-Arginine Availability Modulates Local Nitric Oxide Production and Parasite Killing in Experimental Trypanosomiasis , 2000, Infection and Immunity.

[70]  Namangala,et al.  Trypanosoma brucei brucei infection impairs MHC class II antigen presentation capacity of macrophages , 2000, Parasite immunology.

[71]  P. De Baetselier,et al.  Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines. , 2000, The Journal of infectious diseases.

[72]  R. Kaushik,et al.  Experimental African Trypanosomiasis: Differences in Cytokine and Nitric Oxide Production by Macrophages from Resistant and Susceptible Mice , 2000, Pathobiology.

[73]  R. Kaushik,et al.  Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice. , 1999, Experimental parasitology.

[74]  K. Chang,et al.  Roles of free GPIs in amastigotes of Leishmania. , 1999, Molecular and biochemical parasitology.

[75]  J. M. Mansfield,et al.  IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. , 1999, Cellular immunology.

[76]  C. Muriuki,et al.  Cytokine mRNA profiles in trypanotolerant and trypanosusceptible cattle infected with the protozoan parasite Trypanosoma congolense: protective role for interleukin-4? , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[77]  H. Filutowicz,et al.  Resistance to the African trypanosomes is IFN-gamma dependent. , 1998, Journal of immunology.

[78]  L. Vanhamme,et al.  A VSG Expression Site–Associated Gene Confers Resistance to Human Serum in Trypanosoma rhodesiense , 1998, Cell.

[79]  Z. Lun,et al.  Trypanosoma evansi and T. equiperdum: distribution, biology, treatment and phylogenetic relationship (a review). , 1998, Veterinary parasitology.

[80]  R. Saya,et al.  Trypanosoma congolense infection of trypanotolerant N'Dama (Bos taurus) cattle is associated with decreased secretion of nitric oxide by interferon‐γ‐activated monocytes and increased transcription of interleukin‐10 , 1998, Parasite immunology.

[81]  M. Ferguson,et al.  The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. , 1998, Journal of immunology.

[82]  K. Taylor,et al.  Immune responses of cattle to African trypanosomes: protective or pathogenic? , 1998, International journal for parasitology.

[83]  J. Grootenhuis,et al.  The trypanocidal Cape buffalo serum protein is xanthine oxidase , 1997, Infection and Immunity.

[84]  T. Slifer,et al.  IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. , 1997, Journal of immunology.

[85]  J. F. Albright,et al.  Innate control of the early course of infection in mice inoculated with Trypanosoma musculi. , 1997, Cellular immunology.

[86]  S. Daulouède,et al.  Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. , 1995, The American journal of tropical medicine and hygiene.

[87]  E. Zweygarth,et al.  A comparison of susceptibility to stocks of Trypanosoma simiae of Glossina pallidipes originating from allopatric populations in Kenya , 1995, Medical and veterinary entomology.

[88]  F. Liew,et al.  Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection , 1994, Infection and immunity.

[89]  Diana J L Williams,et al.  African Buffalo Serum Contains Novel Trypanocidal Protein , 1994, The Journal of eukaryotic microbiology.

[90]  M. V. van Velthuysen,et al.  Phagocytosis by glomerular endothelial cells in infection-related glomerulopathy. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[91]  B. Veyret,et al.  Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. , 1992, Experimental parasitology.

[92]  H. Tabel,et al.  Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections. , 1991, The Journal of parasitology.

[93]  G. Cross.  Cellular and genetic aspects of antigenic variation in trypanosomes. , 1990, Annual review of immunology.

[94]  S. Hajduk,et al.  Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. , 1989, The Journal of biological chemistry.

[95]  L. Rickman,et al.  How do African game animals control trypanosome infections? , 1988, Parasitology today.

[96]  A. L. D. de Gee,et al.  Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. , 1988, Journal of immunology.

[97]  D. Devine,et al.  Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense , 1986, Infection and immunity.

[98]  T. Pearson,et al.  Antibody responses in resistant and susceptible inbred mice infected with Trypanosoma congolense. , 1986, Immunology.

[99]  J. F. Albright,et al.  Murine natural resistance to Trypanosoma lewisi involves complement component C3 and radiation-resistant, silica dust-sensitive effector cells , 1985, Infection and immunity.

[100]  A. Ferrante,et al.  Alternative pathway activation of complement by African trypanosomes lacking a glycoprotein coat , 1983, Parasite immunology.

[101]  R. E. Kuhn,et al.  Destruction of Trypanosoma cruzi by Natural killer cells. , 1982, Science.